Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin …

CA Bousman, JM Stevenson… - Clinical …, 2023 - Wiley Online Library
Serotonin reuptake inhibitor antidepressants, including selective serotonin reuptake
inhibitors (SSRIs; ie, citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, and …

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake …

JK Hicks, JR Bishop, K Sangkuhl… - Clinical …, 2015 - Wiley Online Library
Selective serotonin reuptake inhibitors (SSRIs) are primary treatment options for major
depressive and anxiety disorders. CYP2D6 and CYP2C19 polymorphisms can influence the …

Clinical pharmacogenetics implementation consortium guideline (CPIC®) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

JK Hicks, K Sangkuhl, JJ Swen… - Clinical …, 2017 - pmc.ncbi.nlm.nih.gov
CYP2D6 and CYP2C19 polymorphisms affect the exposure, efficacy and safety of tricyclic
antidepressants (TCAs), with some drugs being affected by CYP2D6 only (eg, nortriptyline …

Association of CYP2C19 and CYP2D6 poor and intermediate metabolizer status with antidepressant and antipsychotic exposure: a systematic review and meta …

F Milosavljević, N Bukvić, Z Pavlović, Č Miljević… - JAMA …, 2021 - jamanetwork.com
Importance Precise estimation of the drug metabolism capacity for individual patients is
crucial for adequate dose personalization. Objective To quantify the difference in the …

Peripheral biomarkers of major depression and antidepressant treatment response: current knowledge and future outlooks

BS Gadad, MK Jha, A Czysz, JL Furman… - Journal of affective …, 2018 - Elsevier
Background In recent years, we have accomplished a deeper understanding about the
pathophysiology of major depressive disorder (MDD). Nevertheless, this improved …

[HTML][HTML] Pharmacogenomics in psychiatry practice: the value and the challenges

A Alchakee, M Ahmed, L Eldohaji, H Alhaj… - International journal of …, 2022 - mdpi.com
The activity of cytochrome P450 enzymes is influenced by genetic and nongenetic factors;
hence, the metabolism of exogenous psychotropic medications and potentially some …

[HTML][HTML] Influence of CYP2C19 metabolizer status on escitalopram/citalopram tolerability and response in youth with anxiety and depressive disorders

SL Aldrich, EA Poweleit, CA Prows, LJ Martin… - Frontiers in …, 2019 - frontiersin.org
In pediatric patients, the selective serotonin reuptake inhibitors (SSRIs) escitalopram and
citalopram (es/citalopram) are commonly prescribed for anxiety and depressive disorders …